Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

The global burden of hepatitis B virus (HBV) is enormous, with 257 million persons
chronically infected, resulting in more than 880,000 deaths per year worldwide. HBV exists …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …

At least 10 hepatitis B virus (HBV) genotypes (A to J) with distinct geographic distributions
and several HBV mutants, including precore/core promoter mutations and pre-S/S deletion …

Hepatitis B is one of the most common infectious diseases globally. It has been estimated
that there are 350 million chronic hepatitis B virus (HBV) carriers worldwide. The prevalence …

More than 400 million people worldwide are chronically infected by the hepatitis B virus. The
virus is responsible for more than 300000 cases of liver cancer every year and for similar …

Worldwide about 350 million people are chronic carriers of the hepatitis B virus (HBV). The
infection can cause acute and chronic liver disease including cirrhosis and hepatocellular …

Hepatitis B virus (HBV) is a hepatotropic virus and an important human pathogen. There are
an estimated 296 million people in the world that are chronically infected by this virus, and …

Background The risk of hepatocellular carcinoma (HCC) increases with increasing level of
hepatitis B virus (HBV) in serum (viral load). However, it is unclear whether genetic …

Outcomes of chronic hepatitis B virus (HBV) infection are heterogeneous. Estimates of
annual incidence of cirrhosis and hepatocellular carcinoma (HCC) are 2–10% and 1–3 …